Guangxin Bio-Intelligent Manufacturing Technology Innovation (Shenzhen) Co., Ltd. announced that it has raised CNY 120 million a round of funding on December 21, 2023. The transaction included participation from new investors, Star Lake Bioscience Co., Inc.Zhaoqing Guangdong for CNY 61.2 million and Guangdong Guangxin Innovation Research Institute Co., Ltd. for CNY 58.8 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.26 CNY | +1.62% | -2.19% | +34.33% |
Apr. 23 | China stocks down, dragged by cyclical shares; HK shares up | RE |
Apr. 22 | Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.33% | 1.44B | |
-6.56% | 27.18B | |
+21.63% | 25.15B | |
+6.53% | 11.14B | |
+11.82% | 5.12B | |
+12.04% | 4.21B | |
-14.44% | 3.56B | |
+3.19% | 3.44B | |
-4.91% | 2.83B | |
+24.81% | 2.76B |
- Stock Market
- Equities
- 600866 Stock
- News Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
- Guangxin Bio-Intelligent Manufacturing Technology Innovation Co., Ltd. announced that it has received CNY 120 million in funding from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Guangdong Guangxin Innovation Research Institute Co., Ltd.